(2E)-2-[(Benzyloxy)imino]-3-(4-hydroxyphenyl)-N-[(4-sulfamoylphenyl)methyl]propanamide

ID: ALA4483677

PubChem CID: 155540629

Max Phase: Preclinical

Molecular Formula: C23H23N3O5S

Molecular Weight: 453.52

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  NS(=O)(=O)c1ccc(CNC(=O)/C(Cc2ccc(O)cc2)=N/OCc2ccccc2)cc1

Standard InChI:  InChI=1S/C23H23N3O5S/c24-32(29,30)21-12-8-18(9-13-21)15-25-23(28)22(14-17-6-10-20(27)11-7-17)26-31-16-19-4-2-1-3-5-19/h1-13,27H,14-16H2,(H,25,28)(H2,24,29,30)/b26-22+

Standard InChI Key:  CHLLBTSJOUDGTR-XTCLZLMSSA-N

Molfile:  

 
     RDKit          2D

 32 34  0  0  0  0  0  0  0  0999 V2000
   46.5758  -22.0807    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   46.1713  -21.3749    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   45.7623  -22.0781    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   39.8098  -17.6975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.8087  -18.5171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.5167  -18.9260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.2264  -18.5166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.2236  -17.6939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.5149  -17.2887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.5165  -19.7432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.2241  -20.1520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.2239  -20.9692    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.5161  -21.3776    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   41.9319  -19.7436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.6396  -20.1523    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.9321  -18.9264    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   43.3474  -19.7439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.0550  -20.1527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.0511  -20.9674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.7579  -21.3761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.4667  -20.9676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.4642  -20.1462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.7569  -19.7412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.8792  -20.9667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.5125  -16.4715    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   39.8085  -20.9688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.1007  -21.3772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3952  -20.9673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6879  -21.3750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6873  -22.1931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3999  -22.6017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.1043  -22.1916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  6 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 11 14  1  0
 14 15  1  0
 14 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 21  2  1  0
  2 24  1  0
  9 25  1  0
 13 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4483677

    ---

Associated Targets(Human)

CA1 Tclin Carbonic anhydrase I (13240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA9 Tclin Carbonic anhydrase IX (8255 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA12 Tclin Carbonic anhydrase XII (6231 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 453.52Molecular Weight (Monoisotopic): 453.1358AlogP: 2.47#Rotatable Bonds: 9
Polar Surface Area: 131.08Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 9.42CX Basic pKa: CX LogP: 3.46CX LogD: 3.45
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.34Np Likeness Score: -0.66

References

1. Mujumdar P, Kopecka J, Bua S, Supuran CT, Riganti C, Poulsen SA..  (2019)  Carbonic Anhydrase XII Inhibitors Overcome Temozolomide Resistance in Glioblastoma.,  62  (8): [PMID:30925064] [10.1021/acs.jmedchem.9b00282]

Source